Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial

(2010) Gordon JS Rustin et al.   LANCET

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

(2009) Andreas du Bois et al.   CANCER

Efficacy of pegylated liposomal doxorubicin (PLD) plus carboplatin in ovarian cancer patients who recur within six to twelve months: A phase II study

(2009) Patti Power et al.   GYNECOLOGIC ONCOLOGY

Ovarian cancer

(2009) Bryan T Hennessy et al.   LANCET

Multiple imputation in a large-scale complex survey: a practical guide

(2009) Y. He et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Use of Multiple Imputation in the Epidemiologic Literature

(2008) M. A. Klebanoff et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

The role of secondary cytoreduction in the management of the first relapse in epithelial ovarian cancer

(2008) H. Oksefjell et al.   ANNALS OF ONCOLOGY

Missing Data Analysis: Making It Work in the Real World

(2008) John W. Graham   Annual Review of Psychology

Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis

(2008) Robert E. Bristow et al.   GYNECOLOGIC ONCOLOGY

Nonplatinum Topotecan Combinations Versus Topotecan Alone for Recurrent Ovarian Cancer: Results of a Phase III Study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group

(2008) Jalid Sehouli et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwest Oncology Group Protocol S0200)

(2007) David S. Alberts et al.   GYNECOLOGIC ONCOLOGY